World Trade Factory™

Tharimmune Shares Drop Premarket Following FDA Feedback on Plan for Lead Clinical Asset

Tharimmune Shares Drop Premarket Following FDA Feedback on Plan for Lead Clinical Asset

By Robb M. Stewart Tharimmune's shares were under pressure Thursday despite the company's lead clinical asset receiving what it said was positive feedback from the Food and Drug Administration on...

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.